文献速递头痛与眩晕脑血管病

女性偏头痛与2型糖尿病关联的E3N队列研究

Associations Between Migraine and Type 2 Diabetes in Women: Findings From the E3N Cohort Study.
PubMed 文献 · JAMA Neurol · 2019-01-01

基于法国E3N前瞻性队列中74 247名基线无2型糖尿病的女性,随访10年发生2372例2型糖尿病。与无偏头痛史者相比,有活动性偏头痛的女性发生2型糖尿病的多变量校正风险比为0.70(95%CI 0.58-0.85);活动性偏头痛患病率在糖尿病诊断前24年间由22%(95%CI 16%-27%)线性降至11%(95%CI 10%-12%),诊断后22年维持在约11%的平台。

要点

  • 有活动性偏头痛的女性2型糖尿病发病风险较低,多变量校正HR为0.70(95%CI 0.58-0.85)。
  • 活动性偏头痛患病率在2型糖尿病诊断前24年由22%降至11%,诊断后约22年维持约11%。
  • 结果提示偏头痛与2型糖尿病之间可能存在随时间变化的反向关联,机制尚待研究。

核心结论

  • 有活动性偏头痛的女性发生2型糖尿病的风险低于无偏头痛史的女性,且活动性偏头痛患病率在2型糖尿病诊断前呈线性下降。

研究设计与样本

  • 法国E3N前瞻性人群队列研究,1990年启动,纳入1925至1950年出生的女性。
  • 纳入2002年随访问卷且偏头痛信息可用的女性,排除 prevalent 2型糖尿病后,最终74 247名女性于2004至2014年随访。
  • 偏头痛为自我报告,2型糖尿病为经药物治疗者,通过药品报销数据库识别;统计分析于2018年3月进行。

主要发现

  • 74 247名参与者基线平均(SD)年龄61(6)岁,均无2型糖尿病,10年随访期间发生2372例2型糖尿病。
  • 活动性偏头痛女性对比无偏头痛史女性,单变量HR为0.80(95%CI 0.67-0.96),多变量校正HR为0.70(95%CI 0.58-0.85)。
  • 校正潜在2型糖尿病危险因素后,活动性偏头痛患病率在糖尿病诊断前24年间由22%(95%CI 16%-27%)线性降至11%(95%CI 10%-12%),诊断后22年维持约11%的平台。

临床怎么用

  • 对女性偏头痛患者,不应据此认为其2型糖尿病风险低而放松代谢危险因素管理。
  • 偏头痛病史与2型糖尿病诊断前后的时间关系可作为进一步机制研究的线索。

局限性

  • 偏头痛为自我报告,2型糖尿病仅识别经药物治疗者,可能漏诊未治疗病例。
  • 队列为法国女性教师等参保人群,外推至其他人群需谨慎。
  • 研究为观察性设计,不能确立因果关系或排除残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Little is known about the associations between migraine and type 2 diabetes and the temporality of the association between these 2 diseases. OBJECTIVE: To evaluate the association between migraine and type 2 diabetes incidence as well as the evolution of the prevalence of active migraine before and after type 2 diabetes diagnosis. DESIGN, SETTING, AND PARTICIPANTS: We used data from the E3N cohort study, a French prospective population-based study initiated in 1990 on a cohort of women born between 1925 and 1950. The E3N study participants are insured by a health insurance plan that mostly covers teachers. From the eligible women in the E3N study, we included those who completed the 2002 follow-up questionnaire with information available on migraine. We then excluded prevalent cases of type 2 diabetes, leaving a final sample of women who were followed up between 2004 and 2014. All potential occurrences of type 2 diabetes were identified through a drug reimbursement database. Statistical analyses were performed in March 2018. EXPOSURES: Self-reported migraine occurrence. MAIN OUTCOMES AND MEASURES: Pharmacologically treated type 2 diabetes. RESULTS: From the 98 995 women in the study, 76 403 women completed the 2002 follow-up survey. Of these, 2156 were excluded because they had type 2 diabetes, leaving 74 247 women. Participants had a mean (SD) age of 61 (6) years at baseline, and all were free of type 2 diabetes. During 10 years of follow-up, 2372 incident type 2 diabetes cases occurred. A lower risk of type 2 diabetes was observed for women with active migraine compared with women with no migraine history (univariate hazard ratio, 0.80 [95% CI, 0.67-0.96], multivariable-adjusted hazard ratio, 0.70 [95% CI, 0.58-0.85]). We also observed a linear decrease in active migraine prevalence from 22% (95% CI, 16%-27%) to 11% (95% CI, 10%-12%) during the 24 years prior to diabetes diagnosis, after adjustment for potential type 2 diabetes risk factors. A plateau of migraine prevalence around 11% was then observed for 22 years after diagnosis. CONCLUSIONS AND RELEVANCE: We observed a lower risk of developing type 2 diabetes for women with active migraine and a decrease in active migraine prevalence prior to diabetes diagnosis. Further targeted research should focus on understanding the mechanisms involved in explaining these findings.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Fagherazzi G, El Fatouhi D, Fournier A, et al. Associations Between Migraine and Type 2 Diabetes in Women: Findings From the E3N Cohort Study. JAMA Neurol. 2019. PMID: 30556831. doi:10.1001/jamaneurol.2018.3960

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。